Endovascular grafting for aortoiliac occlusive disease

L. A. Sanchez, R. A. Wain, F. J. Veith, Jacob Cynamon, R. T. Lyon, T. Ohki

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aortoiliac occlusive disease is a significant cause of lower extremity ischemic symptoms. Over the past two decades, most patients have been treated with a variety of surgical procedures, including aortofemoral and extra- anatomic bypasses. Most recently, percutaneous balloon angioplasty and stents have been successfully used for the treatment of limited lilac lesions. New endovascular grafts that combine vascular grafts with stents in a device with new characteristics may allow the successful treatment of patients with extensive aortoiliac occlusive disease in a less invasive fashion. In our early experience, the endovascular grafts were constructed with Palmaz balloon-expandable stents and standard polytetrafluoroethylene (PTFE) grafts. The 18-month primary and secondary patency rates were 89% and 100%, respectively, with a limb salvage rate of 94%. Endovascular grafts can be successfully used to treat patients with extensive aortoiliac occlusive disease, with excellent early results. Long-term results and further graft improvements will define their role in the treatment of patients with aortoiliac occlusive disease.

Original languageEnglish (US)
Pages (from-to)297-309
Number of pages13
JournalSeminars in Vascular Surgery
Volume10
Issue number4
StatePublished - 1997

Fingerprint

Transplants
Stents
Limb Salvage
Balloon Angioplasty
Polytetrafluoroethylene
Blood Vessels
Lower Extremity
Therapeutics
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sanchez, L. A., Wain, R. A., Veith, F. J., Cynamon, J., Lyon, R. T., & Ohki, T. (1997). Endovascular grafting for aortoiliac occlusive disease. Seminars in Vascular Surgery, 10(4), 297-309.

Endovascular grafting for aortoiliac occlusive disease. / Sanchez, L. A.; Wain, R. A.; Veith, F. J.; Cynamon, Jacob; Lyon, R. T.; Ohki, T.

In: Seminars in Vascular Surgery, Vol. 10, No. 4, 1997, p. 297-309.

Research output: Contribution to journalArticle

Sanchez, LA, Wain, RA, Veith, FJ, Cynamon, J, Lyon, RT & Ohki, T 1997, 'Endovascular grafting for aortoiliac occlusive disease', Seminars in Vascular Surgery, vol. 10, no. 4, pp. 297-309.
Sanchez LA, Wain RA, Veith FJ, Cynamon J, Lyon RT, Ohki T. Endovascular grafting for aortoiliac occlusive disease. Seminars in Vascular Surgery. 1997;10(4):297-309.
Sanchez, L. A. ; Wain, R. A. ; Veith, F. J. ; Cynamon, Jacob ; Lyon, R. T. ; Ohki, T. / Endovascular grafting for aortoiliac occlusive disease. In: Seminars in Vascular Surgery. 1997 ; Vol. 10, No. 4. pp. 297-309.
@article{cdba19950b064e7f95207f7cc2cd3f0c,
title = "Endovascular grafting for aortoiliac occlusive disease",
abstract = "Aortoiliac occlusive disease is a significant cause of lower extremity ischemic symptoms. Over the past two decades, most patients have been treated with a variety of surgical procedures, including aortofemoral and extra- anatomic bypasses. Most recently, percutaneous balloon angioplasty and stents have been successfully used for the treatment of limited lilac lesions. New endovascular grafts that combine vascular grafts with stents in a device with new characteristics may allow the successful treatment of patients with extensive aortoiliac occlusive disease in a less invasive fashion. In our early experience, the endovascular grafts were constructed with Palmaz balloon-expandable stents and standard polytetrafluoroethylene (PTFE) grafts. The 18-month primary and secondary patency rates were 89{\%} and 100{\%}, respectively, with a limb salvage rate of 94{\%}. Endovascular grafts can be successfully used to treat patients with extensive aortoiliac occlusive disease, with excellent early results. Long-term results and further graft improvements will define their role in the treatment of patients with aortoiliac occlusive disease.",
author = "Sanchez, {L. A.} and Wain, {R. A.} and Veith, {F. J.} and Jacob Cynamon and Lyon, {R. T.} and T. Ohki",
year = "1997",
language = "English (US)",
volume = "10",
pages = "297--309",
journal = "Seminars in Vascular Surgery",
issn = "0895-7967",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Endovascular grafting for aortoiliac occlusive disease

AU - Sanchez, L. A.

AU - Wain, R. A.

AU - Veith, F. J.

AU - Cynamon, Jacob

AU - Lyon, R. T.

AU - Ohki, T.

PY - 1997

Y1 - 1997

N2 - Aortoiliac occlusive disease is a significant cause of lower extremity ischemic symptoms. Over the past two decades, most patients have been treated with a variety of surgical procedures, including aortofemoral and extra- anatomic bypasses. Most recently, percutaneous balloon angioplasty and stents have been successfully used for the treatment of limited lilac lesions. New endovascular grafts that combine vascular grafts with stents in a device with new characteristics may allow the successful treatment of patients with extensive aortoiliac occlusive disease in a less invasive fashion. In our early experience, the endovascular grafts were constructed with Palmaz balloon-expandable stents and standard polytetrafluoroethylene (PTFE) grafts. The 18-month primary and secondary patency rates were 89% and 100%, respectively, with a limb salvage rate of 94%. Endovascular grafts can be successfully used to treat patients with extensive aortoiliac occlusive disease, with excellent early results. Long-term results and further graft improvements will define their role in the treatment of patients with aortoiliac occlusive disease.

AB - Aortoiliac occlusive disease is a significant cause of lower extremity ischemic symptoms. Over the past two decades, most patients have been treated with a variety of surgical procedures, including aortofemoral and extra- anatomic bypasses. Most recently, percutaneous balloon angioplasty and stents have been successfully used for the treatment of limited lilac lesions. New endovascular grafts that combine vascular grafts with stents in a device with new characteristics may allow the successful treatment of patients with extensive aortoiliac occlusive disease in a less invasive fashion. In our early experience, the endovascular grafts were constructed with Palmaz balloon-expandable stents and standard polytetrafluoroethylene (PTFE) grafts. The 18-month primary and secondary patency rates were 89% and 100%, respectively, with a limb salvage rate of 94%. Endovascular grafts can be successfully used to treat patients with extensive aortoiliac occlusive disease, with excellent early results. Long-term results and further graft improvements will define their role in the treatment of patients with aortoiliac occlusive disease.

UR - http://www.scopus.com/inward/record.url?scp=0031450706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031450706&partnerID=8YFLogxK

M3 - Article

C2 - 9431600

AN - SCOPUS:0031450706

VL - 10

SP - 297

EP - 309

JO - Seminars in Vascular Surgery

JF - Seminars in Vascular Surgery

SN - 0895-7967

IS - 4

ER -